Xeris Biopharma Holdings Inc (XERS)
3.225
0.00 (0.00%)
USD |
NASDAQ |
Nov 04, 16:00
3.23
0.00 (0.00%)
After-Hours: 20:00
Xeris Biopharma Holdings Total Liabilities (Quarterly): 351.02M for June 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | 351.02M |
March 31, 2024 | 345.79M |
December 31, 2023 | 329.38M |
September 30, 2023 | 323.92M |
June 30, 2023 | 315.14M |
March 31, 2023 | 291.31M |
December 31, 2022 | 299.34M |
September 30, 2022 | 247.98M |
June 30, 2022 | 244.67M |
March 31, 2022 | 241.17M |
December 31, 2021 | 209.13M |
September 30, 2021 | 133.72M |
June 30, 2021 | 131.61M |
March 31, 2021 | 123.25M |
Date | Value |
---|---|
December 31, 2020 | 125.39M |
September 30, 2020 | 156.05M |
June 30, 2020 | 141.43M |
March 31, 2020 | 89.39M |
December 31, 2019 | 94.55M |
September 30, 2019 | 84.44M |
June 30, 2019 | 59.10M |
March 31, 2019 | 53.87M |
December 31, 2018 | 44.62M |
September 30, 2018 | 42.47M |
June 30, 2018 | 28.92M |
March 31, 2018 | 28.71M |
December 31, 2017 | 102.83M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
89.39M
Minimum
Mar 2020
351.02M
Maximum
Jun 2024
220.75M
Average
241.17M
Median
Mar 2022
Total Liabilities (Quarterly) Benchmarks
Zoetis Inc | 9.205B |
Zevra Therapeutics Inc | 111.93M |
NovaBay Pharmaceuticals Inc | 4.542M |
Palatin Technologies Inc | 10.85M |
iBio Inc | 7.41M |
Total Liabilities (Quarterly) Related Metrics
Total Assets (Quarterly) | 331.73M |
Shareholders Equity (Quarterly) | -19.29M |
Debt to Equity Ratio | -11.95 |
Current Ratio | 2.256 |
Net Debt Paydown Yield | -2.56% |